Freehand SPECT Combined with 3-Dimensional Light Detection and Ranging as Alternative Means of Specimen Scanning During Prostate Cancer Surgery
Prostate-specific membrane antigen (PSMA) has rapidly been established as a target for prostate cancer management for diagnosis, staging, and image-guided therapy ([1][1] , [2][2]). Nonetheless, during de novo [99mTc]Tc-PSMA radioguided surgery, it is challenging to assess primary tumor margins.
Authors
- Fijs W. B. van Leeuwen (ORCID: https://orcid.org/0000-0002-6844-4025)
- Henk G. van der Poel (ORCID: https://orcid.org/0000-0002-8772-1120)
- Matthias N. van Oosterom (ORCID: https://orcid.org/0000-0003-0306-2568)
- Leon J. Slof (ORCID: https://orcid.org/0009-0002-7897-8589)
- Daphne D. D. Rietbergen (ORCID: https://orcid.org/0000-0001-9873-6179)
- Pim J. van Leeuwen (ORCID: https://orcid.org/0000-0002-5531-6104)
- Anne‐Claire Berrens (ORCID: https://orcid.org/0000-0002-3328-384X)
- Giusi Pisano (ORCID: https://orcid.org/0000-0001-9627-5065)
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Leiden University Medical Center (NL)
- The Netherlands Cancer Institute (NL)
- Amsterdam University Medical Centers (NL)
Publication Details
- Journal
- Journal of Nuclear Medicine
- Published
- 2024-10-03
- DOI
- https://doi.org/10.2967/jnumed.124.268256
- Citations
- 3
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.26